Featured story
Lung Cancer Patients Live Longer With Immune Therapy
MONDAY, April 16, 2018 (The New York Times) — Odds of survival can greatly improve for people with the most common type of lung cancer if they are given a new drug that activates the immune system along with chemotherapy, a major new study has shown.
The findings, medical experts say, should change the way doctors treat lung cancer: Patients with this form of the disease should receive immunotherapy as early as possible.
You might have also missed…
More activity, healthier diet tied to extended survival after colon cancer
Apr. 17, Reuters
E-Cigs Like JUUL Are ‘Undermining’ Efforts to Keep Kids Away From Tobacco, Senators Say
Apr. 18, Fortune
What’s the Difference Between an HSA, FSA, and HRA?
Apr. 16, SELF
Scientists create a biomedical tattoo to monitor for a sign of cancer
Apr. 18, STAT News
